Israel · Delayed Price · Currency is ILS · Price in ILA BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of ILS 1.68 billion. The enterprise value is 1.52 billion.
| Market Cap | 1.68B |
| Enterprise Value | 1.52B |
Important Dates
The last earnings date was Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 40.09 million shares outstanding. The number of shares has increased by 3.85% in one year.
| Current Share Class | 40.09M |
| Shares Outstanding | 40.09M |
| Shares Change (YoY) | +3.85% |
| Shares Change (QoQ) | -8.91% |
| Owned by Insiders (%) | 17.04% |
| Owned by Institutions (%) | 26.05% |
| Float | 27.93M |
Valuation Ratios
The trailing PE ratio is 60.60 and the forward PE ratio is 42.85.
| PE Ratio | 60.60 |
| Forward PE | 42.85 |
| PS Ratio | 9.47 |
| PB Ratio | 7.03 |
| P/TBV Ratio | 7.03 |
| P/FCF Ratio | 45.97 |
| P/OCF Ratio | 39.01 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 65.29, with an EV/FCF ratio of 41.49.
| EV / Earnings | 54.87 |
| EV / Sales | 8.55 |
| EV / EBITDA | 65.29 |
| EV / EBIT | 83.55 |
| EV / FCF | 41.49 |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.34 |
| Quick Ratio | 2.81 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.91 |
| Debt / FCF | 0.58 |
| Interest Coverage | 4.44 |
Financial Efficiency
Return on equity (ROE) is 12.55% and return on invested capital (ROIC) is 31.47%.
| Return on Equity (ROE) | 12.55% |
| Return on Assets (ROA) | 3.31% |
| Return on Invested Capital (ROIC) | 31.47% |
| Return on Capital Employed (ROCE) | 6.16% |
| Weighted Average Cost of Capital (WACC) | 5.25% |
| Revenue Per Employee | 1.38M |
| Profits Per Employee | 214,354 |
| Employee Count | 129 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.34 |
Taxes
In the past 12 months, BrainsWay has paid 309,415 in taxes.
| Income Tax | 309,415 |
| Effective Tax Rate | 1.11% |
Stock Price Statistics
The stock price has increased by +123.80% in the last 52 weeks. The beta is 0.15, so BrainsWay's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | +123.80% |
| 50-Day Moving Average | 4,542.34 |
| 200-Day Moving Average | 3,403.90 |
| Relative Strength Index (RSI) | 42.06 |
| Average Volume (20 Days) | 115,574 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BrainsWay had revenue of ILS 177.50 million and earned 27.65 million in profits. Earnings per share was 0.69.
| Revenue | 177.50M |
| Gross Profit | 134.03M |
| Operating Income | 18.16M |
| Pretax Income | 27.96M |
| Net Income | 27.65M |
| EBITDA | 20.89M |
| EBIT | 18.16M |
| Earnings Per Share (EPS) | 0.69 |
Balance Sheet
The company has 185.13 million in cash and 21.17 million in debt, with a net cash position of 163.96 million or 4.09 per share.
| Cash & Cash Equivalents | 185.13M |
| Total Debt | 21.17M |
| Net Cash | 163.96M |
| Net Cash Per Share | 4.09 |
| Equity (Book Value) | 239.31M |
| Book Value Per Share | 6.27 |
| Working Capital | 173.88M |
Cash Flow
In the last 12 months, operating cash flow was 43.09 million and capital expenditures -6.52 million, giving a free cash flow of 36.57 million.
| Operating Cash Flow | 43.09M |
| Capital Expenditures | -6.52M |
| Depreciation & Amortization | 2.53M |
| Net Borrowing | -2.59M |
| Free Cash Flow | 36.57M |
| FCF Per Share | 0.91 |
Margins
Gross margin is 75.51%, with operating and profit margins of 10.23% and 15.58%.
| Gross Margin | 75.51% |
| Operating Margin | 10.23% |
| Pretax Margin | 15.75% |
| Profit Margin | 15.58% |
| EBITDA Margin | 11.77% |
| EBIT Margin | 10.23% |
| FCF Margin | 20.60% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.85% |
| Shareholder Yield | -3.85% |
| Earnings Yield | 1.64% |
| FCF Yield | 2.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 22, 2011. It was a reverse split with a ratio of 0.25.
| Last Split Date | May 22, 2011 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
BrainsWay has an Altman Z-Score of 4.74 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.74 |
| Piotroski F-Score | 5 |